Oseltamivir Impurity 150, with the CAS number 220478-98-8, is a chemical compound associated with the antiviral medication oseltamivir, commonly used to treat influenza. This impurity is a byproduct that may arise during the synthesis of oseltamivir and is important for quality control in pharmaceutical manufacturing. The characteristics of this substance typically include its molecular structure, which is related to the oseltamivir framework but differs in specific functional groups or substituents. It may exhibit distinct physical properties such as solubility, melting point, and spectral characteristics, which can be determined through analytical techniques like NMR, HPLC, or mass spectrometry. Understanding the presence and behavior of impurities like Oseltamivir Impurity 150 is crucial for ensuring the safety, efficacy, and regulatory compliance of the final pharmaceutical product. Additionally, the identification and quantification of such impurities are essential for maintaining the integrity of drug formulations and for meeting the standards set by regulatory agencies.

Oseltamivir Impurity 150

220478-98-8: Oseltamivir Impurity 150, with the CAS number 220478-98-8, is a chemical compound associated with the antiviral medication oseltamivir, commonly used to treat influenza. This impurity is a byproduct that may arise during the synthesis of oseltamivir and is important for quality control in pharmaceutical manufacturing. The characteristics of this substance typically include its molecular structure, which is related to the oseltamivir framework but differs in specific functional groups or substituents. It may exhibit distinct physical properties such as solubility, melting point, and spectral characteristics, which can be determined through analytical techniques like NMR, HPLC, or mass spectrometry. Understanding the presence and behavior of impurities like Oseltamivir Impurity 150 is crucial for ensuring the safety, efficacy, and regulatory compliance of the final pharmaceutical product. Additionally, the identification and quantification of such impurities are essential for maintaining the integrity of drug formulations and for meeting the standards set by regulatory agencies.

CAS 220478-98-8

Oseltamivir Impurity 150

Oseltamivir Impurity 89

Ref: 4Z-O-11121

Oseltamivir Impurity 87

Ref: 4Z-O-11119